Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Withings BodyScan 2 Now Available in the US, Setting a Standard in Preventive Health and Longevity Monitoring

Withings is a global leader in connected health.

News provided by

Withings

Jul 15, 2026, 07:00 ET

Share this article

Share toX

Share this article

Share toX

The first home health station to deliver cardiac, vascular, and metabolic analysis with expanded longevity insights—available in real time on a redesigned HD handle display, with DEXA-level body composition correlation.

HD Handle Display • Higher-Precision Body Composition • Longevity Scan • Blood Pressure Insights • SpO2 • CES 2026 Innovation Award Honoree

BOSTON, July 15, 2026 /PRNewswire/ -- Withings, the pioneer in connected health and inventor of the first connected scale, today announced that Withings BodyScan 2 ($599.95) is now available in the United States and is FSA/HSA eligible. Measurements are displayed in real time on an ultra-readable color screen embedded in the handle, empowering individuals to better understand their health and extend their healthy years—one measurement at a time.

Continue Reading
Body Scan 2
Body Scan 2

"BodyScan 2 provides a comprehensive assessment of cardiovascular and metabolic health. Our goal is simple: help people and their physicians move from reactive healthcare to truly preventive care—enabling earlier intervention, better health decisions, and ultimately extending healthy years of life for millions." — Eric Carreel, Chairman and Co-founder, Withings

Two Tailored Scans: A Daily Habit and a Weekly Longevity Assessment

BodyScan 2 adapts to everyday life with two complementary scans—one designed for daily monitoring, the other for a deeper weekly assessment of long-term health and longevity.

  • Daily Scan (30 seconds): Essential morning measurements, including weight, fat/muscle/water composition and trends, visceral fat index and trends, heart rate, and Vascular Age via Pulse Wave Velocity.
  • Longevity Scan (about 90 seconds): A comprehensive weekly assessment that includes all Daily Scan measurements, plus a 6-lead ECG, Heart Age, Blood Oxygen Levels (SpO₂), and Nerve Response Score. These advanced biomarkers are combined into a comprehensive Longevity Analysis, available directly in the Withings app.

Together, the Daily Scan and Weekly Longevity Scan transform a growing set of cardiovascular, metabolic, vascular, and neurological biomarkers into a continuous picture of long-term health. By tracking how the body evolves mechanically, metabolically, and vascularly over time, BodyScan 2 empowers individuals and their physicians to detect changes earlier, make more informed decisions, and support healthier aging.

Precision Body Architecture: Professional-Grade 6-Zone Body Composition

BodyScan 2 uses a proprietary 13-frequency Bioimpedance Spectroscopy (BIS) system to deliver independent fat mass and muscle mass readings for each of 6 body segments: right arm, left arm, trunk, right leg, left leg, and core.

  • 13-Frequency BIS: Zone-level data per body segment, pinpointing exactly where training is having an effect. BodyScan 2 offers more than 6x the frequency range of standard basic scales6. Clinical multi-frequency body composition devices operating on 6 frequencies carry price tags exceeding $17,000. BodyScan 2 operates on 13 frequencies for $599.95.
  • Longitudinal Muscle Mass Tracking: Early detection of age-related muscle loss linked to falls, metabolic decline, and reduced longevity
  • Bone Mass Trending: A proxy for osteoporosis risk over time, especially relevant for post-menopausal women and men over 50

Metabolic Wellness

BodyScan 2 measures a unique set of metabolic indicators that go beyond what traditional scales typically track - nerve response, visceral fat, and glucose resilience - to help users better understand how their daily habits influence their overall metabolic wellness over time. Whether pursuing weight management goals, navigating GLP-1 treatments, or simply wanting to understand how lifestyle choices shape overall wellness, BodyScan 2 helps users monitor meaningful changes over time.

  • Glucose Resilience³: An exclusive Withings score combining nerve health and visceral fat levels to show how daily habits shape metabolic wellness. Compatible with Lingo®, Abbott's continuous glucose monitor for people 18+ years and not on insulin, Lingo provides insight on how nutrition, exercise, sleep and stress can affect glucose enabling a proactive approach to making behavior and lifestyle changes.
  • Nerve Response Score: An exclusive wellness metric that provides insight into nerve health by measuring the body's natural response to a gentle electrical signal through the feet. Track changes over time as part of your overall metabolic journey.
  • Visceral Fat Tracking: Uses 6-zone multi-frequency bioimpedance spectroscopy across the scale and handle to estimate visceral fat separately from overall body fat. Unlike traditional scales that provide only a single body fat measurement, BodyScan 2 provides a more detailed view of body composition. Visceral fat is independently associated with insulin resistance, cardiovascular disease, and systemic inflammation.7

Cardiovascular Health

BodyScan 2 combines ECG2, ICG, and PPG technology to help you track your heart health, understand what it means, and make early lifestyle changes that support a longer, healthier life.

  • 6-Lead ECG2 & Cardiac Function: BodyScan 2 combines AFib detection via a 6-lead ECG2 with Impedance Cardiography (ICG) to provide insights into both the electrical and mechanical aspects of cardiac function estimating Cardiac Responsiveness and Efficiency.
  • Heart Age: The first home device to combine electrical and mechanical cardiac measurements to estimate Heart Age, helping users better understand how their cardiovascular health compares with people of the same chronological age.
  • Blood Pressure Insights: Track blood pressure measurements over time to better understand long-term trends and support informed conversations with your healthcare provider.
  • Blood Oxygen (SpO₂): Measure blood oxygen saturation over time to establish a personal baseline and better understand changes in your wellness metrics.

Design, Withings+, and Availability

Designed in France, BodyScan 2 completes a full scan in 90 seconds on a single tempered-glass surface with 8 ITO-embedded electrodes and 4 stainless steel electrodes in a retractable handle with a bright HD color screen. Battery life runs up to 15 months per charge.

Every BodyScan 2 includes a complimentary one-month trial of Withings+5 ($9.95/month or $99.50/year), which unlocks advanced health scores including Heart Age and Glucose Resilience3, an AI Health Assistant, personalized trend analysis, and a Lifetime Guarantee.

Withings BodyScan 2 is available starting July 15, 2026 at withings.com in the US for $599.95.

About Withings

A pioneer in real-life health monitoring, Withings created the first connected scale in 2009 and has continually innovated to offer an ecosystem of clinically validated connected health devices, used by over 15 million people worldwide and by numerous renowned healthcare centers and research institutes. The Withings ecosystem measures over 90 biomarkers. Your body already knows. Withings helps you hear it. Visit withings.com.

Press Contact
Alex McKechnie
[email protected]
475.399.4056

1Internal comparative study between Withings BodyScan measurements and DEXA scan results. 99% correlation observed on fat mass results. Individual results may vary. BodyScan 2 is not a medical device for diagnostic purposes.

2The 6-lead ECG and atrial fibrillation (AFib) detection features are medically regulated. These features are enabled in BodyScan 2 by Withings Scan Monitor 2.0, the FDA-cleared software (510(k) K230812) that powers ECG and AFib detection on the device — the clearance applies to this software, not to the BodyScan 2 hardware itself. All other features described are intended to support general wellness and are not intended for the diagnosis, treatment, cure, mitigation, or prevention of any disease.

3Glucose Resilience is intended for general wellness and fitness purposes and is not intended to diagnose, treat, cure, or prevent any disease. Feature rolls out in the Withings+ app before end of 2026. BodyScan 2's weight, body composition, and related wellness metrics are not intended to diagnose, treat, cure, or prevent any disease and are not a substitute for professional medical advice. Always consult a qualified healthcare professional regarding your health.

5Subject to Withings terms and conditions, available at: https://www.withings.com/us/en/legal/services-terms-and-conditions

6Based on an internal comparison as of June 2026 between BodyScan 2's 13 bioelectrical frequencies against six consumer smart scales priced under $200 in the US with an average of 2 frequencies.

7Neeland IJ et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. The Lancet Diabetes & Endocrinology, 2019. Gastaldelli A. Role of visceral fat in insulin resistance and type 2 diabetes. Nutrition, Metabolism and Cardiovascular Diseases, 2022.Associations of Different Adipose Tissue Depots with Insulin Resistance: A Systematic Review and Meta-analysis of Observational Studies. PMID: 26686961.

About Abbott's Lingo Continuous Glucose Monitor: The Lingo Glucose System is intended for users 18 years and older not on insulin. It is not intended for diagnosis of diseases, including diabetes. The Lingo program does not guarantee that everyone will achieve the same results as individual responses may vary. Consult your healthcare professional before making changes to your diet or exercise regimen or if you have an eating disorder or a history of eating disorders. For more information, visit www.hellolingo.com.
Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read or understood through the use of this device.

SOURCE Withings

21%

more press release views with 
Request a Demo

Modal title

Also from this source

Withings Launches Withings Medical, Bringing Clinical Care to Medicare-Eligible Patients Under CMS's New ACCESS Model

Withings Launches Withings Medical, Bringing Clinical Care to Medicare-Eligible Patients Under CMS's New ACCESS Model

Withings, a leader in connected health and at-home monitoring, today announced Withings Medical, a new clinical care service marking the company's...

The Buyback Pays Off: Withings Confirms Full-Year Profitability for 2025, Driven by U.S. Market Dominance

The Buyback Pays Off: Withings Confirms Full-Year Profitability for 2025, Driven by U.S. Market Dominance

Withings today announces it has reached full year profitability in 2025. Since 2019, the company has grown global revenue approximately 90%, with the ...

More Releases From This Source

Explore

Fitness/Wellness

Fitness/Wellness

Medical Equipment

Medical Equipment

Health Care & Hospitals

Health Care & Hospitals

New Products & Services

New Products & Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.